Skip to main content
. 2022 Nov 30;14(12):2664. doi: 10.3390/pharmaceutics14122664

Figure 6.

Figure 6

D/P study of NFT ASDs: (a) dissolved NFT concentration in a donor chamber after 120 min as a function of the applied NFT dose. TM was used as a medium. (b) Transmembrane flux as a function of NFT concentration in the donor phase. TM was used as a medium. (c) Same as (a) except that SIF was used as a medium. (d) Same as (b) except that SIF was used as a medium. Symbols: crystalline NFT (), HPMCAS ASD (), and Eudragit ASD ().